3-(2-甲基-1,3-二氧代茚-2-基)哌啶-2,6-二酮 | 76059-11-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 中文名称: 3-(2-甲基-1,3-二氧代茚-2-基)哌啶-2,6-二酮
• 英文名称: 3-(2-methyl-1,3-dioxo-1H-inden-2-yl)piperidine-2,6-dione
• 英文别名: 3-[2-(1,3-Dioxo-2-methylindanyl)]glutarimid；3-(2-(1,3-Dioxo-2-methylindanyl))glutarimide；3-(2-methyl-1,3-dioxoinden-2-yl)piperidine-2,6-dione
• CAS: 76059-11-5
• 化学式: C₁₅H₁₃NO₄
• 分子量: 271.273
• InChiKey: QJBBPYKMCVMMTC-UHFFFAOYSA-N

物化性质

• 沸点：
  414.36°C (rough estimate)
• 密度：
  1.2078 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  80.3
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-溴哌啶-2,6-二酮 、 2-甲基-1,3-茚满二酮 在 sodium 作用下， 以33%的产率得到3-(2-甲基-1,3-二氧代茚-2-基)哌啶-2,6-二酮
  参考文献：
  名称：

  沙利度胺类似物 1,3-茚二酮的合成及致畸活性

  摘要：

  合成了一些沙利度胺 - 类似的 1,3 - 茚满二酮，并在小鼠中进行了致畸研究。发现比沙利度胺 (1) 更强的致畸活性。这排除了转酰基作用是沙利度胺致畸性的可能原因。

  DOI：

  10.1002/ardp.19803130602

文献信息

• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
  申请人：Arvinas, Inc.

  公开号：US20180099940A1

  公开（公告）日：2018-04-12

  The present disclosure relates to bifunctional compounds, which find utility to degrade and (inhibit) Androgen Receptor. In particular, the present disclosure is directed to compounds, which contain on one end a cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds Androgen Receptor, such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present disclosure exhibits a broad range of pharmacological activities associated with compounds according to the present disclosure, consistent with the degradation/inhibition of Androgen Receptor.

  本公开涉及双功能化合物，其用于降解和（抑制）雄激素受体。具体而言，本公开涉及包含一端结合到E3泛素连接酶的谷氨酰腺苷环配体，另一端结合到雄激素受体的部分的化合物，使得雄激素受体与泛素连接酶靠近，以实现雄激素受体的降解（和抑制）。本公开展示了与根据本公开涉及的化合物相关的广泛的药理活性范围，与雄激素受体的降解/抑制一致。
• IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
  申请人：Arvinas, Inc.

  公开号：US20150291562A1

  公开（公告）日：2015-10-15

  The description relates to imide-based compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

  该描述涉及基于亚醰基的化合物，包括包含它们的双官能团化合物，这些化合物在靶向泛素化调节中发挥作用，特别是根据本发明的双官能团化合物抑制各种多肽和其他蛋白质的降解和/或抑制。具体来说，该描述提供了一种化合物，其中一端含有与小脑素E3泛素连接酶结合的配体，另一端含有结合目标蛋白的基团，使目标蛋白靠近泛素连接酶，以实现该蛋白的降解（和抑制）。可以合成表现出与几乎任何类型的靶向多肽的降解/抑制一致的广泛药理活性的化合物。
• Compounds and methods for the targeted degradation of androgen receptor
  申请人：Arvinas, Inc.

  公开号：US10584101B2

  公开（公告）日：2020-03-10

  The present disclosure relates to bifunctional compounds, which find utility to degrade and (inhibit) Androgen Receptor. In particular, the present disclosure is directed to compounds, which contain on one end a cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds Androgen Receptor, such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present disclosure exhibits a broad range of pharmacological activities associated with compounds according to the present disclosure, consistent with the degradation/inhibition of Androgen Receptor.

  本公开涉及双功能化合物，它们可用于降解和（抑制）雄激素受体。特别是，本公开涉及的化合物一端含有与 E3 泛素连接酶结合的脑龙配体，另一端含有与雄激素受体结合的分子，这样雄激素受体就被置于泛素连接酶附近，从而实现对雄激素受体的降解（和抑制）。本公开的化合物具有广泛的药理活性，与雄激素受体的降解/抑制作用相一致。
• Imide-based modulators of proteolysis and associated methods of use
  申请人：YALE UNIVERSITY

  公开号：US11220515B2

  公开（公告）日：2022-01-11

  The description relates to imide-based compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.

  本说明涉及亚胺基化合物，包括包含亚胺基化合物的双官能化合物，这些化合物可用作靶向泛素化的调节剂，特别是各种多肽和其他蛋白质的抑制剂，根据本发明的双官能化合物可降解和/或以其他方式抑制这些多肽和蛋白质。具体而言，本发明提供的化合物一端含有与脑龙 E3 泛素连接酶结合的配体，另一端含有与靶蛋白结合的分子，从而使靶蛋白靠近泛素连接酶，以实现对该蛋白的降解（和抑制）。可以合成出具有广泛药理活性的化合物，这些化合物几乎可以降解/抑制任何类型的目标多肽。
• [EN] IMIDE-BASED MODULATORS OF PROTEOLYSIS AND METHODS OF USE<br/>[FR] MODULATEURS DE PROTÉOLYSE À BASE D'IMIDE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：UNIV YALE

  公开号：WO2019148055A9

  公开（公告）日：2019-09-26